It didn’t take long for the other shoe to drop in government challenges to major health insurance mergers, with a federal trial court smacking down the proposed $48 billion purchase of Cigna Inc. by Anthem Inc.
Judge Amy Berman Jackson of the U.S. District Court for the District of Columbia said the merger would disrupt competition in the market for “national accounts” and wouldn’t create any merger-specific efficiencies that could excuse that disruption.
Jackson’s decision comes only two weeks after her colleague on the court, Judge John D. Bates, stopped the proposed $37 billion merger of Aetna Inc. and Humana Inc. (See my prior story here.)
Many health-care and antitrust attorneys that I spoke to said the combined force of both decisions should frustrate other proposed mega-mergers in the health insurance industry. The parties to these two proposed mergers, Anthem, Cigna, Aetna and Humana are four of the five largest health insurers, along with the Minnesota-based UnitedHealth Group.
Aetna and Humana haven’t yet decided to appeal the court order blocking their merger, but Anthem immediately filed an appeal with the U.S. Court of Appeals for the District of Columbia Circuit. At the same time, Cigna seemed hesitant to commit to fighting for the merger.
And that sets up one of the more peculiar aspects of the Anthem-Cigna merger trial. As the insurers fought the Department of Justice in court, executives from Cigna already seemed to have soured on the deal.
“Cigna appears to have played the part of the kid in class who rolls his eyes every time the student in the front row speaks,” Douglas Ross, an antitrust and health-care attorney at Davis Wright Tremaine in Seattle, told me.
Unfortunately, Cigna and Anthem were supposed to be on the same debate team, and the judge noticed, and wasn’t impressed, by their discord,” he added.
David Balto, an antitrust attorney in Washington, warned that even if the appeals court were to reverse Jackson’s ruling and allow the deal to go through, the animosity between the two parties could be dangerous for the combined company. “A shotgun wedding like this won't pass muster with the courts,” he said.
Between a low probability that either highly fact-dependent trial court ruling would be reversed on appeal, and the strong possibility that the parties have had enough, these deals, at least, appear to be dead.
Read the full story on the reaction to the merger here.
Stay on top of new developments in health law and regulation with a free trial to the Health Law Resource Center.
Learn more about Bloomberg Law and sign up for a free trial.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)